Multiple eruptive dermatofibromas related to imatinib treatment

J Eur Acad Dermatol Venereol. 2014 Jul;28(7):979-81. doi: 10.1111/jdv.12328. Epub 2013 Dec 10.

Authors

M Llamas-Velasco¹, J Fraga, G E Solano-López, J L Steegmann, A García Diez, L Requena

Affiliation

¹ Department of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain.

PMID: 24321053
DOI: 10.1111/jdv.12328

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects*
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use
Benzamides / adverse effects*
Benzamides / pharmacology
Benzamides / therapeutic use
Biopsy
Female
Histiocytoma, Benign Fibrous / chemically induced*
Histiocytoma, Benign Fibrous / diagnosis*
Histiocytoma, Benign Fibrous / pathology
Humans
Imatinib Mesylate
Immunosuppression Therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Male
Middle Aged
Piperazines / adverse effects*
Piperazines / pharmacology
Piperazines / therapeutic use
Pyrimidines / adverse effects*
Pyrimidines / pharmacology
Pyrimidines / therapeutic use
Skin / drug effects
Skin / pathology
Treatment Outcome

Substances

Antineoplastic Agents
Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate